Current Neuropharmacology
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
Current Neuropharmacology
CURR NEUROPHARMACOL
ISSN / eISSN
1570-159X / 1875-6190
Aims and Scope
Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.
The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.
The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.
Subject Area
PHARMACOLOGY & PHARMACY
NEUROSCIENCES
CiteScore
9.40
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Medicine - Pharmacology (medical) | Q1 | #21/260 |
| Medicine - Psychiatry and Mental Health | Q1 | #45/531 |
| Medicine - Neurology | Q1 | #20/175 |
| Medicine - Neurology (clinical) | Q1 | #43/373 |
| Medicine - Pharmacology | Q1 | #45/301 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| NEUROSCIENCES - SCIE | Q1 |
| PHARMACOLOGY & PHARMACY - SCIE | Q1 |
H-index
58
Country/Area of Publication
ENGLAND
Publisher
Bentham Science Publishers B.V.
Publication Frequency
Quarterly
Year Publication Started
2003
Annual Article Volume
149
Open Access
NO
Contact
BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More